Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab

Rogiers, A. I. (Speaker)

Activity: Talk or presentationTalk or presentation at a conference

Period28 Nov 2018
Event titleImmunotherapy Bridge 2018
Event typeConference